Background {#Sec1}
==========

Oral implant surgery is a routine treatment to replace lost teeth \[[@CR1]\]. Although oral implants are expected to have a high rate of success, implant failures do occur \[[@CR2]\].

Implant failures can be classified as early failures or late failures. Early implant failures occur before the prosthetic restoration, and one of their possible causes might be postoperative infection because of bacterial contamination during the implant insertion \[[@CR3]\]. For this reason, the use of perioperative antibiotics has been suggested to prevent postoperative infections and oral implant failures \[[@CR4]\].

However, the use of prophylactic antibiotics to reduce the incidence of postoperative infections and oral implant failures remains a controversial issue \[[@CR5], [@CR6]\]. Some reviews recommended a single dose of 1 g, 2 g or 3 g of amoxicillin preoperatively but found no evidence to support the postoperative use of a prophylactic antibiotic after oral implant surgery among healthy patients \[[@CR2], [@CR7]\].

Markedly, there seems to be no consensus among dentists, oral implantologists, periodontists and maxillofacial surgeons over the use of antibiotics to prevent post-implant infections and oral implant failures \[[@CR8]--[@CR12]\].

The inconsistent use of antibiotics has become an important epidemiologic problem due to the development of bacterial resistance and the risk of superinfection \[[@CR13]\], resulting in considerable human and economic costs \[[@CR14]\]. Other adverse effects, such as secondary infections, interactions with other medications, gastro-intestinal discomfort, toxicity and allergic reactions, should also be considered \[[@CR7]\].

The government and healthcare services of the Netherlands are pursuing several strategies against antibiotic resistance, which include encouraging health professionals to comply with strict guidelines when prescribing antibiotics in an effort to reduce inappropriate antibiotic prescriptions by at least 50% in 2019 \[[@CR15]\].

In the Netherlands, oral implant surgery is mainly performed by maxillofacial surgeons and oral implantologists, i.e. dentists who completed a three-year master's qualification. Antibiotics are the most prescribed drugs in dentistry in the Netherlands. National data revealed that 41.0% of all prescriptions written by dentists during 2015 in the Netherlands were for amoxicillin. Metronidazole and clindamycin accounted for 2.5% of all medications prescribed by dentists \[[@CR16]\]..

Nevertheless, the guidelines used in the Netherlands for oral implant surgery do not include a clear policy on the use of prophylactic antibiotics among healthy patients. The Dutch Association of Oral Implantology (NVOI), recommending new publications on this topic in the future, proposed amendments to these guidelines \[[@CR17]\].

New research assessing the effectiveness of prophylactic antibiotics for oral implant surgery has been performed in recent years \[[@CR7], [@CR18], [@CR19]\].

Moreover, several studies focused on antibiotic prescribing habits in conjunction with oral implant surgeries in different countries have been published recently \[[@CR8]--[@CR12]\]. Markedly, no data were available concerning the situation in the Netherlands. Consequently, it is imperative to assess the current situation in the Netherlands and compare it with similar conditions in other countries.

Therefore, the primary aim of this study was to determine whether antibiotic prophylaxis is commonly prescribed in the Netherlands by general dentists, maxillofacial surgeons and oral implantologists in conjunction with oral implant surgery among healthy patients. The secondary aim was to assess the type and amount (expressed in milligrams: mg) of antibiotics prescribed to evaluate whether any consensus has been reached and the current recommendations made by the last published evidence have been followed \[[@CR2], [@CR7]\].

Methods {#Sec2}
=======

This observational cross-sectional study is based on a web survey, and it is reported according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines \[[@CR20]\].

The questionnaire, developed by Deeb et al. (2015) \[[@CR12]\], was translated and slightly adjusted for use in the Netherlands to collect data concerning the prescription rates of preventive antibiotics among general dental practitioners, maxillofacial surgeons, periodontists and oral implantologists in conjunction with oral implant therapy. The explicit authorization of Deeb and the co-authors was obtained to use their questionnaire. The translated and adjusted questionnaire was evaluated for comprehensibility and logical order by an experienced oral implantologist, who is involved in the training of dentists in the Netherlands. The formulation of the questions was found adequate and valid to assess the intended objectives.

Setting {#Sec3}
-------

The Netherlands is a member state of the European Union with, in 2018, a population of approximately 17.1 million \[[@CR21]\]. In January 2018, roughly 8800 dentists were employed in the Netherlands, including about 320 oral implantologists and 80 periodontists. In addition, at that time, there were about 290 practicing maxillofacial surgeons \[[@CR22]\].

Participants {#Sec4}
------------

In February 2018, an email was sent to a representative sample of 600 general dental practitioners, randomly selected from the official register of qualified dentists of the Royal Dutch Dental Association (KNMT), and to all 302 oral implantologists, periodontists and maxillofacial surgeons recognized by the NVOI as oral health care providers who place oral implants and whose email addresses were publicly available.

The only eligibility criteria considered for inviting potential participants to the study was inclusion in the NVOI and KNMT lists. The KNMT maintains an updated file of all licensed dentists in the Netherlands, but does not know whether dentists are active in dentistry. For this reason, it was determined the group of all dentists aged 64 years or less with a known domicile and/or work address in the Netherlands because this group was expected to work in dentistry. A sample of 600 dentists from this group, consisting of about 8800 dentists, was drawn with the SPSS SAMPLE procedure. This was performed by a "Third Party" research institute commissioned by the KNMT. This institute specialized in the management and administration of web surveys and offers support in data collection. The email addresses of NVOI members are publicly available on the NVOI website.

Subsequently, the "Third Party" research institute sent the invitation by e-mail to all potential participants and collected the data. These email messages contained an individual link to a web-based questionnaire and a brief introduction to the study objectives. The participants were assured that the research data were collected anonymously, and it was made clear that by answering the questionnaire, participants consented to the use of the data collected by the survey for the study purpose. All efforts were made to protect the participants' privacy and anonymity as no personal data of the participants (name, surname, address and telephone number) were collected. In addition, no email addresses were stored or saved by the authors so the participants could not be contacted again. For these reasons, this specific study did not require an ethics statement by an institutional review board (ethics committee) before the study began. Two reminder emails were sent to all potential respondents after two and four weeks; after six weeks, the data collection was closed.

The "Third Party" research institute made the collected data available for use in an encrypted manner so that the authors did not have access to any personal information of the participants, including their email addresses.

A total of 28 potential participants could not be reached because of an incorrect email address. Therefore, the final sample consisted of 874 potential participants: 578 general dental practitioners and 296 oral implantologists, periodontists and maxillofacial surgeons.

Variables {#Sec5}
---------

Information was gathered regarding qualifications and work experience, demographic details and most commonly prescribed preventive antibiotic in case of oral implant placement, including duration and dosage. Based on their statements regarding dosage and period of intake, the total milligrams (mg) prescribed per oral health professional and oral implant surgery was calculated.

Data sources and measurement {#Sec6}
----------------------------

Each link found in the email messages directed the user to a questionnaire, which could only be answered once. The questionnaire contained predominantly close-ended questions. Participants were allowed to add other answer options and additional information (Additional file [1](#MOESM1){ref-type="media"}).

Statistical methods {#Sec7}
-------------------

All data were analyzed using International Business Machines Corporation (IBM) Statistical Package for Social Sciences (SPSS) for Windows Version 24 (IBM Corporation, released 2012, Armonk, New York). To begin, by means of descriptive statistics, an overview was compiled of the respondents' characteristics in terms of age, sex, type of oral health professional and geographical area. After that, the descriptive analysis continued with only those care providers who had indicated that they place oral implants on a regular basis. Subsequently, their habits regarding prescribing antibiotics before, during or after an oral implant placement were assessed. It was investigated whether antibiotic prescribing habits in oral implant surgery were related to personal characteristics of participants and, for those who prescribe antibiotics, prescription regimens used (chi-squared test and ANOVA). Whether the total amount of prescribed antibiotics varied among certain groups of participants was first investigated by means of ANOVA (F-test) and finally, because the data were not normally distributed, analyzed by means of the Kruskal-Wallis test and Mann-Whitney U test.

Results {#Sec8}
=======

Participants {#Sec9}
------------

Table [1](#Tab1){ref-type="table"} details the different professionals included in the study. Two participants reported that they were not currently working, and they were excluded from the study group. Table 1Professional specializations of participants^\#1^ and current activity in oral implant surgeryprofessional specializationDo place oral implantsDo not place oral implantsOveralln%n%n%General dental practitioner (GDP)115.05927.17032.1GDP & OI209.2209.2Oral implantologist (OI)6730.76730.7OI & periodontist (OI-PERIO)94.110.5104.7Maxillofacial surgeon (MS)4420.210.54520.6Other oral health professional^\#2^41.841.8Not working as oral health professional^\#3^20.920.9Total15169.26730.8218100^\#1^ multiple situations possible / ^\#2^ dentist for orthodontics (3x), maxillofacial prosthodontist /^\#3^ the 2 participants who are not working as oral health professional were excluded from the further analysis of the data

Descriptive data {#Sec10}
----------------

In total, 171 males (79.2%) and 45 females (20.8%) responded to the questionnaire. The mean age of the participants was 48.6 years (*SD* = 11.1). While 24.1% were 39 years or younger, 20.8% were between 40 and 49 years old, and 55.1% were 50 years of age or older.

Most participants (92.3%) graduated from a dental school in the Netherlands: Amsterdam (36.6%), Nijmegen (23.8%), Groningen (21.7%) and Utrecht (10.2%). Almost half of the participants (46.3%) were settled in the western part of the country, with 26.4% in the southern, 17.6% in the eastern and 9.7% in the northern regions.

Oral implant placement and prescribing habits {#Sec11}
---------------------------------------------

Table [1](#Tab1){ref-type="table"} depicts that 69.2% of the participants surveyed indicated that they regularly place oral implants. Of these 151 participants currently performing oral implant surgeries, 66 (43.7%) stated that they regularly prescribe prophylactic antibiotics, while a minority (3.3%, *n* = 5) reported they never do so. In addition, 79 participants (52.3%) indicated they prescribe antibiotics only in certain situations. These situations are presented in Table [2](#Tab2){ref-type="table"}. Table 2Situations in which participants prescribed antibiotics before, after or during oral implant placement^*\#1*^n%Bone grafting7393.6Sinus perforation3342.2Preoperative implant-site infection2937.2Medically compromised patient^\#2^2228.2Past of periodontal disease1417.9Smoking habit1316.7Simultaneous placement of more than 1 dental implant67.7Dentulous patient^\#2^56.4Other situation^\#3^79.0Total^\#4^78100^\#1^ multiple situations possible / ^\#2^ derived from the option 'Other situation', as described by participants / ^\#3^ sinus lift surgery (2x), post-operative complications (2x), treatment under anaesthesia, specific location of dental implant placement, based on microbiological test / ^\#4^ 1 participant did not indicate situation

No statistically significant relationship was found between any of the participants' characteristics and their prescribing habits. (Table [3](#Tab3){ref-type="table"}). Table 3Personal characteristics of participants related to antibiotic prescription habits in oral implant surgeryNeverSome-timesAlwaysOverallFemale^\#1^13.9%7.6%10.7%Mean (SD) age in years^\#2^60.0 (4.8)49.6 (10.1)51.5 (10.8)50.8 (10.4)Type of specialization^\#3^-General dental practitioner20.0%5.1%9.1%7.4%-Oral implantologist and/or periodontist60.0%62.0%65.2%63.3%-Oral surgeon20.0%32.9%25.7%29.3%Graduation in the Netherlands^\#4^100%94.9%90.9%93.3%Place of settlement (part of the country)^\#5^-Southern60.0%20.3%21.2%22.0%-Western40.0%45.6%54.5%49.3%-Eastern17.6%18.2%17.3%-Northern16.5%6.1%11.4%n ^\#6^57966150^\#1^ *p* 0.343 / ^\#2^ *p* 0.071 / ^\#3^ *p* 0.597 / ^\#4^ *p* 0.520 / ^\#5^ *p* 0.173 / ^\#6^ 1 participant did not indicate prescription habitsSD: Standard deviation

Table [4](#Tab4){ref-type="table"} reports the starting times and regimens of the antibiotic prescriptions employed by the participants. Table 4Antibiotic prescribing regimens and starting time of the prescriptions employed by participantsn%n%Only pre-operative4732.4-1 h or immediately4329.6-1 day prior21.4-2 days prior21.4Pre- and post-operative8357.2-1 h or immediately6041.4-1 day prior1812.4-2 days prior53.4Only post-operative128.3Unknown32.1Total145100145100

Preoperative antibiotics: type, dose and dosage {#Sec12}
-----------------------------------------------

The majority of participants who prescribe preoperative antibiotics when placing oral implants advise their patients to start one hour prior to treatment (75.2%) or immediately prior to treatment (3.1%). All others stated that they advise their patients to start one day (16.3%) or two days (5.4%) prior to treatment.

Most participants who prescribe prophylactic antibiotics one hour or immediately prior to implant placement prescribe 2000 mg of amoxicillin to be taken orally (70.3%). Furthermore, 9.9% indicated they prescribe 3000 mg of amoxicillin, and 9.9% indicated they prescribe 500 mg of amoxicillin, in both instances to be taken orally.

More than half of the participants (53.9%) who start antibiotic prophylaxis one or two days prior to implant surgery prescribe 500 mg of amoxicillin to be taken orally three times a day. In addition, 19.3% prescribe a combination of 500/125 mg amoxicillin/clavulanic acid to be taken three times a day (Table [5](#Tab5){ref-type="table"}). Table 5Pre-operative antibiotic regimens prescribed before surgery by participants1 h or immediately priorAntibiotic typeDose (mg)Administrationn%Amoxicillin2.000oral7170.3Amoxicillin500oral109,9Amoxicillin3.000^\#1^oral109.9Amoxicillin1.000oral22.0Amoxicillinother^\#2^oral22.0Amoxicillin600oral11.0Amoxicillin/Clavulanic acid500 / 125oral33.0Amoxicillin/Clavulanic acid2.000oral11.0Clindamycin600oral11.0Total^\#3^1011001 or 2 days priorAntibiotic typeDose (mg)Dosagen%Amoxicillin500oral TID1453.9Amoxicillin400oral TID13.8Amoxicillin500oral BID13.8Amoxicillinother^\#4^oral TID13.8Amoxicillin/Clavulanic acid500 / 125oral TID519.3Clindamycin300oral BID13.8Clindamycin300oral QID13.8Erythromycin (ethylsuccinate form)150oral TID13.8Other^\#5^500oral QD13.8Total^\#6^26100QD: once a day, BID: twice a day, TID: 3 times daily, QID: 4 times daily / ^\#1^ mentioned spontaneously / ^\#2^ varying / ^\#3^ 2 participants did not declare the pre-operative regimen prescribed / ^\#4^ 375 mg, it concerns an antibiotic treatment and not antibiotic prophylaxis / ^\#5^ Zithromax / ^\#6^ 1 participant did not declare the pre-operative regimen prescribed

Postoperative antibiotics: type, dose and dosage {#Sec13}
------------------------------------------------

Of the participants who opt to advise patients to start antibiotic prophylaxis postoperatively, 75.1% prescribe 500 mg of amoxicillin to be taken orally one to four times a day for a period varying from one to eight days (Table [6](#Tab6){ref-type="table"}). Furthermore, 15.2% indicated they prescribe a combination of 500/125 mg amoxicillin/clavulanic to be taken three times a day for a period of five or seven days. Table 6Post-operative antibiotic regimens prescribed after surgery by participantsAntibiotic typeDose (mg)DosageDurationn%Amoxicillin250oral TID5 days11.1Amoxicillin400oral TID5 days11.1Amoxicillin500oral QD3 days11.1Amoxicillin500oral BID7 days11.1Amoxicillin500oral TID1 day44.2Amoxicillin500oral TID3 days22.2Amoxicillin500oral TID5 days2931.4Amoxicillin500oral TID6 days11.1Amoxicillin500oral TID7 days2426.1Amoxicillin500oral TID8 days11.1Amoxicillin500oral TIDother^\#1^2\`2.2Amoxicillin500oral QID2 days11.1Amoxicillin500oral QID4 days11.1Amoxicillin500oral QID5 days22.2Amoxicillin/Clavulanic acid500/125oral TID1 day11.1Amoxicillin/Clavulanic acid500/125oral TID5 days66.5Amoxicillin/Clavulanic acid500/125oral TID7 days88.7Amoxicillin/Clavulanic acid500/125oral QID6 days11.1Amoxicillin/Clavulanic acid500/125oral QID7 days11.1Clindamycin300oral TID7 days11.1Clindamycin300oral QID5 days11.1Clindamycin300oral QID7 days11.1Other^\#2^500oral QD2 days11.1Total^\#3^92100QD: once a day, BID: twice a day, TID: 3 times daily, QID: 4 times daily / ^\#1^ unknown /^\#2^ Zithromax / ^\#3^ 3 participants did not declare the postoperative regimen prescribed

Amounts of prescribed antibiotics {#Sec14}
---------------------------------

On average, participants stated that they prescribe a total of 7018 mg (*SD* = 4325 mg) of prophylactic antibiotics before, during or after oral implant surgery, varying from 500 mg to 14,600 mg with the median lying at 8000 mg. Three participants did not indicate their prescribing regimens, and six did not declare the number of milligrams prescribed (Table [7](#Tab7){ref-type="table"}). Table 7Total amount of antibiotics (mg) prescribed by participants related to their type of working situation and prescription habitsMeanSDMean Rank ^\#1^PType of oral health professional0.029-General dental practitioner (GDP)4150370539.3-Maxillofacial surgeon (MS)6883419568.3-Oral implantologist (OI)7969417975.8Antibiotic prescription habits0.003-Sometimes7799417377.9-Always5913405957.9Antibiotic prescription regimen\< 0.0001-Only pre-operative206046324.9-Only post-operative9250154584.1-Pre- and post-operative9598296391.8Total70184235n = 136 ^\#2\#1^ Kruskal-Wallis test or Mann-Whitney test / ^\#2^ 3 participants did not indicate prescribing regimens and 6 participants did not completely declare the number of mg or did not declare it at all

Notably, maxillofacial surgeons prescribe significantly more antibiotics than oral implantologists and general practitioners (7969 mg versus 6883 mg and 4150 mg; *p* = 0.03).

In particular, the difference between maxillofacial surgeons and general practitioners was statistically significant (*p* = 0.02). Participants who only opted for antibiotics prior to treatment reported prescribing significantly smaller amounts than their colleagues who opted for antibiotics only after treatment and prior to as well as after treatment (2060 mg versus 9250 mg and 9598 mg; *p* \< 0.001). Furthermore, it appears that participants who regularly prescribe an antibiotic prophylaxis in conjunction with oral implant surgery prescribe significantly smaller amounts of antibiotics than participants who prescribe prophylactic antibiotics only in certain circumstances. Conversely, participants who prescribe prophylactic antibiotics only in certain circumstances when inserting oral implants indicated they prescribe longer regimens (pre- and postoperatively) than participants who indicated they regularly prescribe prophylactic antibiotics (*p* = 0.04).

Discussion {#Sec15}
==========

Key results {#Sec16}
-----------

Considering the latest evidence published on this topic, more than two-thirds of the participants in this study do not follow an adequate prophylactic antibiotic regimen. They prescribe prophylactic antibiotics in many situations not defined by the guidelines proposed by the NVOI \[[@CR17]\]. Moreover, there appears to be a lack of consensus regarding the indications for prescribing prophylactic antibiotics in conjunction with oral implant surgery among healthy patients as well as regarding the antibiotic of choice and the regimen selection.

Limitations {#Sec17}
-----------

Before the start of the study, it was unclear how many dentists and maxillofacial surgeons insert oral implants in the Netherlands. For that reason, the research group was composed of all maxillofacial surgeons, periodontists and oral implantologists who are recognized to routinely perform oral implant surgery and an additional random sample of general dental practitioners, who are also qualified to perform this treatment. In this way, the chance of any selection bias was minimized.

Overall, the response rate of 24.9% was not high, but it was considered adequate for a web questionnaire \[[@CR23]\]. While there was no certainty that all dentists, maxillofacial surgeons, periodontists and oral implantologists placing oral implants in the Netherlands were reached, it was considered that the participants in this study properly represented the target population.

The questionnaire was completely anonymous to encourage respondents to answer the questions as truthfully as possible to avoid risk of bias. Nevertheless, the authenticity of the answers obtained was difficult to control. Moreover, as in most survey studies, it is uncertain whether respondents' statements about their behavior match their behavior in practice.

Interpretation {#Sec18}
--------------

In accordance with Esposito et al. \[[@CR2]\], the NVOI guidelines acknowledge that a single preoperative dose of oral antibiotics may slightly decrease implant failures. Nevertheless, standard antibiotic prophylaxis in conjunction with oral implant placement among healthy patients is not recommended. The last published reviews stress the lack of evidence supporting the use of postoperative antibiotics exclusively after surgery or as a combination with preoperative antibiotics \[[@CR2], [@CR7]\]. Preoperative antibiotics are only indicated as bacterial endocarditis prophylaxis for patients with orthopedic implants or in implant surgeries performed on infected sites. Following the NVOI guidelines, the first treatment choice in these situations should be a single dose of oral amoxicillin and clavulanic acid (1000/250 mg) one hour before surgery or, in the event of allergies, oral clindamycin (600 mg) one hour prior to treatment \[[@CR17]\]. However, the last published evidence recommends a single preoperative dose of 1 g, 2 g or 3 g of amoxicillin \[[@CR2], [@CR7]\]. It has also been described recently that penicillin-allergic patients treated with clindamycin may present more risk of suffering oral implant failures \[[@CR24]\].

This study confirms a lack of agreement on the prescription of prophylactic antibiotics in oral implant surgery, as already demonstrated in many other medical situations in which this treatment is an option \[[@CR25]\]. However, in comparison with their colleagues in other countries, dentists, maxillofacial surgeons, periodontists and oral implantologists in the Netherlands seem to prescribe a smaller range of antibiotic types and regimens and seem more cautious in prescribing prophylactic antibiotics. In the UK, a study revealed that approximately 72% of dentists prescribe antibiotics for all oral implant surgery procedures \[[@CR9]\], while a Swedish study revealed that 74% of dentists routinely prescribe antibiotics in conjunction with oral implant surgery \[[@CR10]\].

The prescription patterns of maxillofacial surgeons in the USA revealed that 96% prescribe prophylactic antibiotics for healthy patients \[[@CR12]\], and similar research in Spain found that almost 90% of the dentists studied regularly prescribe antibiotics among healthy patients \[[@CR11]\]. Conversely, it was found that the proportion of dentists in Jordan who prescribe antibiotics in all implant surgeries was around 50% \[[@CR8]\].

The present study found differences in the prescription duration between participants who prescribe prophylactic antibiotics systematically (more often opting for short-term regimens) and those professionals who prescribe prophylactic antibiotics only in certain instances (more often opting for long-term regimens). This is probably related to the fact that the latter more often prescribe prophylactic antibiotics for a particular reason after reflection and a decision-making process.

The discrepancies in the average amount of prophylactic antibiotics prescribed by maxillofacial surgeons and general dentists in the Netherlands might be explained by the relative contrast in the complexity of the surgeries executed by each group. Maxillofacial surgeons may face more complicated treatments than general dentists, which could generate the prescription of heavier prophylactic regimens.

Similar to health care professionals worldwide, oral health professionals performing implant surgery in the Netherlands prescribe too often and too many prophylactic antibiotics. This may lead to an alarming risk of bacterial resistance and the development of other adverse reactions to antibiotics, which potentially generates a serious public health problem and consequently, high societal and economic costs.

Generalisability {#Sec19}
----------------

This survey was conducted among oral healthcare professionals in the Netherlands registered as general dental practitioners, oral implantologists or maxillofacial surgeons who graduated in representative proportions from various dental schools. Combined with the fact that a substantial proportion of the oral health professionals who perform oral implant surgeries participated in this study, it is plausible that the results of the survey broadly reflect the national situation in the Netherlands.

Conclusions {#Sec20}
===========

Antibiotic prophylaxis in conjunction with oral implant surgery among healthy patients is prescribed in the Netherlands on a large scale by general dentists, maxillofacial surgeons, periodontists and oral implantologists. In addition, recommendations based on the last published evidence are frequently not being followed. For this reason, more attention should be paid to the implementation of existing guidelines. New research assessing the effects of different prophylactic antibiotic types, dosages and regimens in healthy patients is also necessary to update evidence-based guidelines.
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**Additional file 1.** Questionnaire. This file contains the English version of the survey sent to participants.

GDP

:   General dental practitioner

IBM

:   International Business Machines Corporation

KNMT

:   Royal Dutch Dental Association

Mg

:   Milligrams

MS

:   Maxillofacial surgeon

NVOI

:   Dutch Association of Oral Implantology

OI

:   Oral implantologist

OI-PERIO

:   Oral implantologist and periodontist

SPSS

:   Statistical Package for Social Sciences

STROBE

:   Strengthening the Reporting of Observational Studies in Epidemiology
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